IGFBP2 and pancreatic ductal adenocarcinoma: In both pancreatic ductal adenocarcinoma (PDAC) and hepatocellular carcinoma (HCC), IGFBP2 induces epithelial-mesenchymal transition (EMT) by activating the NF-κB signaling pathway (66, 67).